Corrigendum to "Type 2 diabetes after a pregnancy with gestational diabetes among first nations women in Australia: The PANDORA study" [Diabetes Res. Clin. Pract. 181 (2021) 109092] [0.03%]
对澳大利亚原住民女性妊娠糖尿病产后2型糖尿病的研究（PANDORA研究）的勘误 [刊载于《糖尿病研究与临床实践》第181期(2021)109092号论文]
Anna J Wood,Jacqueline A Boyle,Elizabeth L M Barr et al.
Anna J Wood et al.
MASLD/MASH and type 2 diabetes: Two sides of the same coin? From single PPAR to pan-PPAR agonists [0.03%]
Masld/mash与2型糖尿病：同一个硬币的两面？从单一ppar到泛ppar激动剂
Michael P Cooreman,Luisa Vonghia,Sven M Francque
Michael P Cooreman
Type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), mainly related to nutrition and lack of physical activity, are both very common conditions, share several disease pathways and clinical manifestatio...
Real-world sex differences in type 2 diabetes patients treated with GLP-1 receptor agonists [0.03%]
胰高血糖素样肽-1受体激动剂治疗的2型糖尿病患者中的真实世界性别差异
Sara Piccini,Giuseppe Favacchio,Emanuela Morenghi et al.
Sara Piccini et al.
Aims: To evaluate the determinants of cardiovascular (CV) protection in men and women treated with glucagon-like peptide-1 receptor agonists (GLP1-RA). Me...
Association of 25-hydroxyvitamin D, lipoprotein-associated phospholipase A2 and asymptomatic coronary artery disease in patients with type 2 diabetes mellitus [0.03%]
25-羟基维生素D、脂蛋白相关磷脂酶A2与2型糖尿病患者无症状冠心病的关系
Qian Zhang,Qing-Qing Zhang,Jiao-Jiao He et al.
Qian Zhang et al.
Aim: To evaluate the relationship of 25-hydroxyvitamin D (25(OH)D), lipoprotein-associated phospholipase A2 (Lp-PLA2), and coronary artery disease (CAD) in type 2 diabetes mellitus (T2DM) patients with no history or sympt...
Intermittently scanned continuous glucose monitoring provides no benefit over structured self-monitoring of blood glucose in type 2 diabetes not on prandial insulin, in the context of diabetes self-management education: GLucose monitoring programme SingaporE (GLiMPSE) [0.03%]
间歇性扫描的持续葡萄糖监测相较于结构化的自我血糖监测在糖尿病教育管理中对不使用餐时胰岛素的2型糖尿病患者没有临床获益：GLucose monitoring programme SingaporE（GLiMPSE）研究
Suresh Rama Chandran,Nabilah Rahman,Mihir Gandhi et al.
Suresh Rama Chandran et al.
Objective: We evaluated the impact of intermittently scanned continuous glucose monitoring(is-CGM)over self-monitoring of blood glucose(SMBG) in the context of diabetes self-management education (DSME) in sub-optimally co...
Randomized Controlled Trial
Diabetes research and clinical practice. 2024 May:211:111678. DOI:10.1016/j.diabres.2024.111678 2024
One abnormal value in oral glucose tolerance test during pregnancy and type 2 diabetes risk: Insights from a 5-Year Follow-Up study [0.03%]
妊娠期口服葡萄糖耐量检查中一个异常值与2型糖尿病风险的关系：一项5年随访研究的启示
Rawia Hussein-Aro,Esther Maor-Sagie,Yoel Toledano et al.
Rawia Hussein-Aro et al.
Objectives: To evaluate the risk of type 2 diabetes(T2D) following one abnormal value(OAbV) in an oral glucose tolerance test(oGTT) performed during pregnancy. ...
Cardiovascular risk reduction in older people with type 2 diabetes mellitus-a comprehensive narrative review [0.03%]
老年2型糖尿病患者心血管风险的降低——全面叙述性综述
Pann Ei Hnynn Si,S Parker,D Abdelhafiz et al.
Pann Ei Hnynn Si et al.
Metabolic targets are controversial in older people with type 2 diabetes due to functional heterogeneity and morbidity burden. Tight blood pressure and metabolic control appears beneficial in fit individuals who are newly diagnosed with typ...
The use of potentially interacting supplement-drug pairs in adults with type 2 diabetes: A large population-based cohort study in the UK Biobank [0.03%]
英国生物样本库中2型糖尿病成人使用的可能具有相互作用的膳食补充剂-药物组合：一项基于人群的大型队列研究
Rong Hua,Chun Sing Lam,Yu Kang Wu et al.
Rong Hua et al.
Aims: To examine the patterns of use of potentially interacting supplement-drug pairs in adults with type 2 diabetes (T2D) in real-world settings, and to explore the impact of potentially interacting supplement-drug pairs...
Corrigendum to "The AMD ANNALS: A continuous initiative for the improvement of type 2 diabetes care" [Diabetes Res. and Clin. Pract. 199 (2023) 110672] [0.03%]
“AMD年鉴：持续改进2型糖尿病护理的连续倡议”一文的勘误(糖尿病研究与临床实践杂志，199卷（2023）110672)
G Russo,P Di Bartolo,R Candido et al.
G Russo et al.
Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population [0.03%]
代谢功能障碍相关脂肪性肝病患者2型糖尿病及其心血管代谢结局
Nicholas W S Chew,Xin Hui Pan,Bryan Chong et al.
Nicholas W S Chew et al.
The metabolic syndrome, characterized by type 2 diabetes mellitus (T2DM), hypertension, hyperlipidemia, and obesity, collectively increases the risk of cardiovascular diseases. Nonalcoholic fatty liver disease (NAFLD) is a prominent manifes...